Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

about

Clinical predictive models for chemotherapy-induced febrile neutropenia in breast cancer patients: a validation study.A model of hematopoietic stem cell proliferation under the influence of a chemotherapeutic agent in combination with a hematopoietic inducing agent.

P2860

Q33778817-D6A21EFA-F284-4B19-8A27-DF66B3ADA7A4 Q41887008-042FDBB2-2013-4822-AE2A-F30D72C83E4C

P2860

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

Item

http://www.wikidata.org/entity/Q35995548

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

@ast

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

@en

type

Item

label

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

@ast

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

@en

prefLabel

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

@ast

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

@en

P1476

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

@en

P2093

Hideo Nakajima

http://www.w3.org/2001/XMLSchema#string

Itaru Sato

http://www.w3.org/2001/XMLSchema#string

Naoki Nakaya

http://www.w3.org/2001/XMLSchema#string

Takeo Shimasaki

http://www.w3.org/2001/XMLSchema#string

Yoshiharu Motoo

http://www.w3.org/2001/XMLSchema#string

P2860

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

Current management of chemotherapy-induced neutropenia: the role of colony-stimulating factors.

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.

P304

860-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2012.556

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228083105

http://www.w3.org/2001/XMLSchema#string

P698

22741007

http://www.w3.org/2001/XMLSchema#string

P932

3362462

http://www.w3.org/2001/XMLSchema#string

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

about

P2860

P2860

Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932